Integrated Screening & Assay Capability Facilitate Peptide Drug Early Discovery

DATE

July 9, 2025

TIME

8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST - Duration: 60 Minutes

Overview

In recent years, peptide-based therapeutics have emerged as a significant class of drugs in the pharmaceutical landscape, offering numerous advantages such as high specificity, potent activity, and relatively low toxicity. These attributes make peptides highly attractive for targeting complex diseases, including cancer, metabolic disorders, and autoimmune conditions. As the demand for innovative peptide drugs continues to grow, the need for advanced technologies and integrated approaches in early discovery becomes paramount.

In this webinar, Dr. Ma will begin by introducing peptide discovery using DNA-encoded library (DEL) technology, including a case study focused on the identification of protein–protein interaction inhibitors. He will then present WuXi AppTec’s capabilities in phage display and mRNA display, supported by corresponding case studies. In the second half, Dr. Xing will showcase the comprehensive bioassay platform and customized strategies for peptide ligand validation. Whether you're exploring peptide therapeutics for the first time or looking to expand your discovery toolkit, this session offers practical guidance and case studies to support your next breakthrough.

Register now for the second webinar in this series, July 10, 2025:

Comprehensive Preclinical Development, DMPK, and Bioanalytical Solutions for Novel Peptide Therapeutics

Key Learning Objectives:

Comprehensive bioassays and customized strategy designed for peptide validation
Peptide synthesis and optimization services are also available to facilitate peptide discovery process
Four peptide discovery platforms (DEL & display technology) available for novel peptide discovery

Who Should Attend:

Peptide researcher
Pharmaceutical & biotech company

Brought to you by:

Speakers

Zhongyao Ma, PhD
Director, WuXi Biology,
WuXi AppTec

Yewei Xing, PhD
Director, WuXi Biology,
WuXi AppTec

Melissa O'Meara
Forensic Science Consultant,
C&EN Media Group

Registration

Forwarded this event? Clear the form

Email Address*

Salutation

First Name*

Last Name*

Company*

Job Title*

City*

State*

Country/Territory/Area*

Business Phone*

Are you currently involved in peptide drug discovery or development?*

Which of the following best describes your interest in peptide discovery platforms?*

Does your organization plan to initiate or expand peptide drug projects within the next 12 months?*

I would like to receive C&EN’s weekly newsletter with the latest in chemistry news

I would like to receive more information on products and services from the American Chemical Society

address2

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

View On Demand Webinars